Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Danner

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Anesthesia and Analgesia|July 29, 2010
Walk a mile in whose shoes?Katherine J Deans, Peter Minneci, Peter Q Eichacker, et al.
Critical Care Medicine|October 11, 2005
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trialPeter Q Eichacker, Robert L Danner, Anthony F Suffredini, et al.
Anesthesia and Analgesia|October 13, 2009
Practice misalignments in randomized controlled trials: Identification, impact, and potential solutionsKatherine J Deans, Peter C Minneci, Robert L Danner, et al.
Annals of Internal Medicine|August 6, 2008
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?Denise A Gonzales, Robert A Star, Steven J Kern, et al.
The Annals of Pharmacotherapy|July 9, 2009
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteriaBrad Moriyama, Stacey A Henning, Melinda M Neuhauser, et al.
Nucleic Acids Research|June 8, 2006
Nitric oxide activation of Erk1/2 regulates the stability and translation of mRNA transcripts containing CU-rich elementsShuibang Wang, Jianhua Zhang, Stephanie Theel, et al.
Critical Care Medicine|April 26, 2020
Individualized Care Is Superior to Standardized Care for the Majority of Critically Ill PatientsIrene Cortés-Puch, Willard N Applefeld, Jeffrey Wang, et al.
Current Fungal Infection Reports|February 27, 2016
Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of VoriconazoleBrad Moriyama, Sameer Kadri, Stacey A Henning, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 12, 2020
Comparative effectiveness research in critically ill patients: risks associated with mischaracterising usual careWillard N Applefeld, Jeffrey Wang, Harvey G Klein, et al.
International Immunopharmacology|July 16, 2003
Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shockMahnaz Badamchian, Mirela O Fagarasan, Robert L Danner, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Anesthesia and Analgesia|July 29, 2010
Walk a mile in whose shoes?Katherine J Deans, Peter Minneci, Peter Q Eichacker, et al.
Critical Care Medicine|October 11, 2005
Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trialPeter Q Eichacker, Robert L Danner, Anthony F Suffredini, et al.
Anesthesia and Analgesia|October 13, 2009
Practice misalignments in randomized controlled trials: Identification, impact, and potential solutionsKatherine J Deans, Peter C Minneci, Robert L Danner, et al.
Annals of Internal Medicine|August 6, 2008
Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?Denise A Gonzales, Robert A Star, Steven J Kern, et al.
The Annals of Pharmacotherapy|July 9, 2009
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteriaBrad Moriyama, Stacey A Henning, Melinda M Neuhauser, et al.
Nucleic Acids Research|June 8, 2006
Nitric oxide activation of Erk1/2 regulates the stability and translation of mRNA transcripts containing CU-rich elementsShuibang Wang, Jianhua Zhang, Stephanie Theel, et al.
Critical Care Medicine|April 26, 2020
Individualized Care Is Superior to Standardized Care for the Majority of Critically Ill PatientsIrene Cortés-Puch, Willard N Applefeld, Jeffrey Wang, et al.
Current Fungal Infection Reports|February 27, 2016
Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of VoriconazoleBrad Moriyama, Sameer Kadri, Stacey A Henning, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 12, 2020
Comparative effectiveness research in critically ill patients: risks associated with mischaracterising usual careWillard N Applefeld, Jeffrey Wang, Harvey G Klein, et al.
International Immunopharmacology|July 16, 2003
Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shockMahnaz Badamchian, Mirela O Fagarasan, Robert L Danner, et al.
Pageof 14